0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Insulin Syringes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-7E7129
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Insulin Syringes Market Insights and Forecast to 2028
BUY CHAPTERS

Insulin Syringes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-7E7129
Report
September 2024
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Insulin Syringes - Market Size

The global market for Insulin Syringes was estimated to be worth US$ 1612 million in 2023 and is forecast to a readjusted size of US$ 2151.9 million by 2030 with a CAGR of 4.1% during the forecast period 2024-2030

Insulin Syringes - Market

Insulin Syringes - Market

An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.
The Insulin Syringes market is expected to be positively impacted by the COVID-19 pandemic. As patients with different health issues such as, diabetes and high blood pressure are at higher risk of getting affected by virus. It is found that the mortality rate is high in a patient with diabetes compared to the general population. The people having diabetes require continuous access to insulin (administrated with syringes or pens) and care.Thus, the adoption of insulin syringes and continuous glucose monitoring devices has increased for close monitoring and optimal management of diabetes. The major factor that contributes to the growth of the insulin syringes market include surge in aging population and increased number of diabetic patients globally. Furthermore, other factors such as favorable government policies related to insulin syringes are the key factors that drive the growth of the market. In addition, surge in incidence of obesity and people adopting an unhealthy lifestyle supplement the growth of market. Moreover, rise in prevalence of various chronic diseases such as type-1 and type-2 diabetes, is another major factor that boosts the market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Syringes, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Syringes by region & country, by Type, and by Application.
The Insulin Syringes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Syringes.
Market Segmentation

Scope of Insulin Syringes - Market Report

Report Metric Details
Report Name Insulin Syringes - Market
Forecasted market size in 2030 US$ 2151.9 million
CAGR 4.1%
Forecasted years 2024 - 2030
Segment by Type:
  • 3/10 CC Syringe
  • 1/2 CC Syringe
  • 1 CC Syringe
  • Others
Segment by Application
  • Hospital
  • Homecare
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon Ltd, Ypsomed AG, Wockhardt Ltd, Medtronic Plc, Abbott Laboratories, Animas Corporation, F. Hoffmann-La Roche, BD, Terumo Corporation, Cardinal Health Inc, Medline Industries, Braun Melunsun, Nipro Medical Corporation, HMD Healthcare Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Insulin Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Insulin Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Insulin Syringes in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Insulin Syringes - Market size in 2030?

Ans: The Insulin Syringes - Market size in 2030 will be US$ 2151.9 million.

Who are the main players in the Insulin Syringes - Market report?

Ans: The main players in the Insulin Syringes - Market are Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon Ltd, Ypsomed AG, Wockhardt Ltd, Medtronic Plc, Abbott Laboratories, Animas Corporation, F. Hoffmann-La Roche, BD, Terumo Corporation, Cardinal Health Inc, Medline Industries, Braun Melunsun, Nipro Medical Corporation, HMD Healthcare Ltd

What are the Application segmentation covered in the Insulin Syringes - Market report?

Ans: The Applications covered in the Insulin Syringes - Market report are Hospital, Homecare, Others

What are the Type segmentation covered in the Insulin Syringes - Market report?

Ans: The Types covered in the Insulin Syringes - Market report are 3/10 CC Syringe, 1/2 CC Syringe, 1 CC Syringe, Others

1 Market Overview
1.1 Insulin Syringes Product Introduction
1.2 Global Insulin Syringes Market Size Forecast
1.2.1 Global Insulin Syringes Sales Value (2019-2030)
1.2.2 Global Insulin Syringes Sales Volume (2019-2030)
1.2.3 Global Insulin Syringes Sales Price (2019-2030)
1.3 Insulin Syringes Market Trends & Drivers
1.3.1 Insulin Syringes Industry Trends
1.3.2 Insulin Syringes Market Drivers & Opportunity
1.3.3 Insulin Syringes Market Challenges
1.3.4 Insulin Syringes Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insulin Syringes Players Revenue Ranking (2023)
2.2 Global Insulin Syringes Revenue by Company (2019-2024)
2.3 Global Insulin Syringes Players Sales Volume Ranking (2023)
2.4 Global Insulin Syringes Sales Volume by Company Players (2019-2024)
2.5 Global Insulin Syringes Average Price by Company (2019-2024)
2.6 Key Manufacturers Insulin Syringes Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Insulin Syringes Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Insulin Syringes
2.9 Insulin Syringes Market Competitive Analysis
2.9.1 Insulin Syringes Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Syringes Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Syringes as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 3/10 CC Syringe
3.1.2 1/2 CC Syringe
3.1.3 1 CC Syringe
3.1.4 Others
3.2 Global Insulin Syringes Sales Value by Type
3.2.1 Global Insulin Syringes Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Insulin Syringes Sales Value, by Type (2019-2030)
3.2.3 Global Insulin Syringes Sales Value, by Type (%) (2019-2030)
3.3 Global Insulin Syringes Sales Volume by Type
3.3.1 Global Insulin Syringes Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Insulin Syringes Sales Volume, by Type (2019-2030)
3.3.3 Global Insulin Syringes Sales Volume, by Type (%) (2019-2030)
3.4 Global Insulin Syringes Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Homecare
4.1.3 Others
4.2 Global Insulin Syringes Sales Value by Application
4.2.1 Global Insulin Syringes Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Insulin Syringes Sales Value, by Application (2019-2030)
4.2.3 Global Insulin Syringes Sales Value, by Application (%) (2019-2030)
4.3 Global Insulin Syringes Sales Volume by Application
4.3.1 Global Insulin Syringes Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Insulin Syringes Sales Volume, by Application (2019-2030)
4.3.3 Global Insulin Syringes Sales Volume, by Application (%) (2019-2030)
4.4 Global Insulin Syringes Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Insulin Syringes Sales Value by Region
5.1.1 Global Insulin Syringes Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Insulin Syringes Sales Value by Region (2019-2024)
5.1.3 Global Insulin Syringes Sales Value by Region (2025-2030)
5.1.4 Global Insulin Syringes Sales Value by Region (%), (2019-2030)
5.2 Global Insulin Syringes Sales Volume by Region
5.2.1 Global Insulin Syringes Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Insulin Syringes Sales Volume by Region (2019-2024)
5.2.3 Global Insulin Syringes Sales Volume by Region (2025-2030)
5.2.4 Global Insulin Syringes Sales Volume by Region (%), (2019-2030)
5.3 Global Insulin Syringes Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Insulin Syringes Sales Value, 2019-2030
5.4.2 North America Insulin Syringes Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Insulin Syringes Sales Value, 2019-2030
5.5.2 Europe Insulin Syringes Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Insulin Syringes Sales Value, 2019-2030
5.6.2 Asia Pacific Insulin Syringes Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Insulin Syringes Sales Value, 2019-2030
5.7.2 South America Insulin Syringes Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Insulin Syringes Sales Value, 2019-2030
5.8.2 Middle East & Africa Insulin Syringes Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insulin Syringes Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Insulin Syringes Sales Value
6.2.1 Key Countries/Regions Insulin Syringes Sales Value, 2019-2030
6.2.2 Key Countries/Regions Insulin Syringes Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Insulin Syringes Sales Value, 2019-2030
6.3.2 United States Insulin Syringes Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Insulin Syringes Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Insulin Syringes Sales Value, 2019-2030
6.4.2 Europe Insulin Syringes Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Insulin Syringes Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Insulin Syringes Sales Value, 2019-2030
6.5.2 China Insulin Syringes Sales Value by Type (%), 2023 VS 2030
6.5.3 China Insulin Syringes Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Insulin Syringes Sales Value, 2019-2030
6.6.2 Japan Insulin Syringes Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Insulin Syringes Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Insulin Syringes Sales Value, 2019-2030
6.7.2 South Korea Insulin Syringes Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Insulin Syringes Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Insulin Syringes Sales Value, 2019-2030
6.8.2 Southeast Asia Insulin Syringes Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Insulin Syringes Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Insulin Syringes Sales Value, 2019-2030
6.9.2 India Insulin Syringes Sales Value by Type (%), 2023 VS 2030
6.9.3 India Insulin Syringes Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Information
7.1.2 Novo Nordisk Introduction and Business Overview
7.1.3 Novo Nordisk Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novo Nordisk Insulin Syringes Product Offerings
7.1.5 Novo Nordisk Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Information
7.2.2 Sanofi Introduction and Business Overview
7.2.3 Sanofi Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sanofi Insulin Syringes Product Offerings
7.2.5 Sanofi Recent Development
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Information
7.3.2 Eli Lilly and Company Introduction and Business Overview
7.3.3 Eli Lilly and Company Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eli Lilly and Company Insulin Syringes Product Offerings
7.3.5 Eli Lilly and Company Recent Development
7.4 Biocon Ltd
7.4.1 Biocon Ltd Company Information
7.4.2 Biocon Ltd Introduction and Business Overview
7.4.3 Biocon Ltd Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biocon Ltd Insulin Syringes Product Offerings
7.4.5 Biocon Ltd Recent Development
7.5 Ypsomed AG
7.5.1 Ypsomed AG Company Information
7.5.2 Ypsomed AG Introduction and Business Overview
7.5.3 Ypsomed AG Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ypsomed AG Insulin Syringes Product Offerings
7.5.5 Ypsomed AG Recent Development
7.6 Wockhardt Ltd
7.6.1 Wockhardt Ltd Company Information
7.6.2 Wockhardt Ltd Introduction and Business Overview
7.6.3 Wockhardt Ltd Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Wockhardt Ltd Insulin Syringes Product Offerings
7.6.5 Wockhardt Ltd Recent Development
7.7 Medtronic Plc
7.7.1 Medtronic Plc Company Information
7.7.2 Medtronic Plc Introduction and Business Overview
7.7.3 Medtronic Plc Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Medtronic Plc Insulin Syringes Product Offerings
7.7.5 Medtronic Plc Recent Development
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Information
7.8.2 Abbott Laboratories Introduction and Business Overview
7.8.3 Abbott Laboratories Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Abbott Laboratories Insulin Syringes Product Offerings
7.8.5 Abbott Laboratories Recent Development
7.9 Animas Corporation
7.9.1 Animas Corporation Company Information
7.9.2 Animas Corporation Introduction and Business Overview
7.9.3 Animas Corporation Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Animas Corporation Insulin Syringes Product Offerings
7.9.5 Animas Corporation Recent Development
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Company Information
7.10.2 F. Hoffmann-La Roche Introduction and Business Overview
7.10.3 F. Hoffmann-La Roche Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.10.4 F. Hoffmann-La Roche Insulin Syringes Product Offerings
7.10.5 F. Hoffmann-La Roche Recent Development
7.11 BD
7.11.1 BD Company Information
7.11.2 BD Introduction and Business Overview
7.11.3 BD Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.11.4 BD Insulin Syringes Product Offerings
7.11.5 BD Recent Development
7.12 Terumo Corporation
7.12.1 Terumo Corporation Company Information
7.12.2 Terumo Corporation Introduction and Business Overview
7.12.3 Terumo Corporation Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Terumo Corporation Insulin Syringes Product Offerings
7.12.5 Terumo Corporation Recent Development
7.13 Cardinal Health Inc
7.13.1 Cardinal Health Inc Company Information
7.13.2 Cardinal Health Inc Introduction and Business Overview
7.13.3 Cardinal Health Inc Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Cardinal Health Inc Insulin Syringes Product Offerings
7.13.5 Cardinal Health Inc Recent Development
7.14 Medline Industries
7.14.1 Medline Industries Company Information
7.14.2 Medline Industries Introduction and Business Overview
7.14.3 Medline Industries Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Medline Industries Insulin Syringes Product Offerings
7.14.5 Medline Industries Recent Development
7.15 Braun Melunsun
7.15.1 Braun Melunsun Company Information
7.15.2 Braun Melunsun Introduction and Business Overview
7.15.3 Braun Melunsun Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Braun Melunsun Insulin Syringes Product Offerings
7.15.5 Braun Melunsun Recent Development
7.16 Nipro Medical Corporation
7.16.1 Nipro Medical Corporation Company Information
7.16.2 Nipro Medical Corporation Introduction and Business Overview
7.16.3 Nipro Medical Corporation Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Nipro Medical Corporation Insulin Syringes Product Offerings
7.16.5 Nipro Medical Corporation Recent Development
7.17 HMD Healthcare Ltd
7.17.1 HMD Healthcare Ltd Company Information
7.17.2 HMD Healthcare Ltd Introduction and Business Overview
7.17.3 HMD Healthcare Ltd Insulin Syringes Sales, Revenue and Gross Margin (2019-2024)
7.17.4 HMD Healthcare Ltd Insulin Syringes Product Offerings
7.17.5 HMD Healthcare Ltd Recent Development
8 Industry Chain Analysis
8.1 Insulin Syringes Industrial Chain
8.2 Insulin Syringes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Insulin Syringes Sales Model
8.5.2 Sales Channel
8.5.3 Insulin Syringes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Insulin Syringes Market Trends
    Table 2. Insulin Syringes Market Drivers & Opportunity
    Table 3. Insulin Syringes Market Challenges
    Table 4. Insulin Syringes Market Restraints
    Table 5. Global Insulin Syringes Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Insulin Syringes Revenue Market Share by Company (2019-2024)
    Table 7. Global Insulin Syringes Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Insulin Syringes Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Insulin Syringes Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Insulin Syringes Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Insulin Syringes Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Insulin Syringes
    Table 13. Global Insulin Syringes Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Syringes as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Insulin Syringes Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Insulin Syringes Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Insulin Syringes Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Insulin Syringes Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Insulin Syringes Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Insulin Syringes Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Insulin Syringes Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Insulin Syringes Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Insulin Syringes Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Insulin Syringes Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Insulin Syringes Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Insulin Syringes Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Insulin Syringes Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Insulin Syringes Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Insulin Syringes Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Insulin Syringes Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Insulin Syringes Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Insulin Syringes Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Insulin Syringes Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Insulin Syringes Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Insulin Syringes Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Insulin Syringes Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Insulin Syringes Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Insulin Syringes Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Insulin Syringes Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Insulin Syringes Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Insulin Syringes Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Insulin Syringes Sales Value by Region (2019-2024) & (%)
    Table 44. Global Insulin Syringes Sales Value by Region (2025-2030) & (%)
    Table 45. Global Insulin Syringes Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Insulin Syringes Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Insulin Syringes Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Insulin Syringes Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Insulin Syringes Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Insulin Syringes Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Insulin Syringes Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Insulin Syringes Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Insulin Syringes Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Insulin Syringes Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Insulin Syringes Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Insulin Syringes Sales Volume, (2025-2030) & (K Units)
    Table 57. Novo Nordisk Company Information
    Table 58. Novo Nordisk Introduction and Business Overview
    Table 59. Novo Nordisk Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Novo Nordisk Insulin Syringes Product Offerings
    Table 61. Novo Nordisk Recent Development
    Table 62. Sanofi Company Information
    Table 63. Sanofi Introduction and Business Overview
    Table 64. Sanofi Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Insulin Syringes Product Offerings
    Table 66. Sanofi Recent Development
    Table 67. Eli Lilly and Company Company Information
    Table 68. Eli Lilly and Company Introduction and Business Overview
    Table 69. Eli Lilly and Company Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Eli Lilly and Company Insulin Syringes Product Offerings
    Table 71. Eli Lilly and Company Recent Development
    Table 72. Biocon Ltd Company Information
    Table 73. Biocon Ltd Introduction and Business Overview
    Table 74. Biocon Ltd Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Biocon Ltd Insulin Syringes Product Offerings
    Table 76. Biocon Ltd Recent Development
    Table 77. Ypsomed AG Company Information
    Table 78. Ypsomed AG Introduction and Business Overview
    Table 79. Ypsomed AG Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Ypsomed AG Insulin Syringes Product Offerings
    Table 81. Ypsomed AG Recent Development
    Table 82. Wockhardt Ltd Company Information
    Table 83. Wockhardt Ltd Introduction and Business Overview
    Table 84. Wockhardt Ltd Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Wockhardt Ltd Insulin Syringes Product Offerings
    Table 86. Wockhardt Ltd Recent Development
    Table 87. Medtronic Plc Company Information
    Table 88. Medtronic Plc Introduction and Business Overview
    Table 89. Medtronic Plc Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Medtronic Plc Insulin Syringes Product Offerings
    Table 91. Medtronic Plc Recent Development
    Table 92. Abbott Laboratories Company Information
    Table 93. Abbott Laboratories Introduction and Business Overview
    Table 94. Abbott Laboratories Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Abbott Laboratories Insulin Syringes Product Offerings
    Table 96. Abbott Laboratories Recent Development
    Table 97. Animas Corporation Company Information
    Table 98. Animas Corporation Introduction and Business Overview
    Table 99. Animas Corporation Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Animas Corporation Insulin Syringes Product Offerings
    Table 101. Animas Corporation Recent Development
    Table 102. F. Hoffmann-La Roche Company Information
    Table 103. F. Hoffmann-La Roche Introduction and Business Overview
    Table 104. F. Hoffmann-La Roche Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. F. Hoffmann-La Roche Insulin Syringes Product Offerings
    Table 106. F. Hoffmann-La Roche Recent Development
    Table 107. BD Company Information
    Table 108. BD Introduction and Business Overview
    Table 109. BD Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. BD Insulin Syringes Product Offerings
    Table 111. BD Recent Development
    Table 112. Terumo Corporation Company Information
    Table 113. Terumo Corporation Introduction and Business Overview
    Table 114. Terumo Corporation Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Terumo Corporation Insulin Syringes Product Offerings
    Table 116. Terumo Corporation Recent Development
    Table 117. Cardinal Health Inc Company Information
    Table 118. Cardinal Health Inc Introduction and Business Overview
    Table 119. Cardinal Health Inc Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Cardinal Health Inc Insulin Syringes Product Offerings
    Table 121. Cardinal Health Inc Recent Development
    Table 122. Medline Industries Company Information
    Table 123. Medline Industries Introduction and Business Overview
    Table 124. Medline Industries Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Medline Industries Insulin Syringes Product Offerings
    Table 126. Medline Industries Recent Development
    Table 127. Braun Melunsun Company Information
    Table 128. Braun Melunsun Introduction and Business Overview
    Table 129. Braun Melunsun Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Braun Melunsun Insulin Syringes Product Offerings
    Table 131. Braun Melunsun Recent Development
    Table 132. Nipro Medical Corporation Company Information
    Table 133. Nipro Medical Corporation Introduction and Business Overview
    Table 134. Nipro Medical Corporation Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Nipro Medical Corporation Insulin Syringes Product Offerings
    Table 136. Nipro Medical Corporation Recent Development
    Table 137. HMD Healthcare Ltd Company Information
    Table 138. HMD Healthcare Ltd Introduction and Business Overview
    Table 139. HMD Healthcare Ltd Insulin Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. HMD Healthcare Ltd Insulin Syringes Product Offerings
    Table 141. HMD Healthcare Ltd Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Insulin Syringes Downstream Customers
    Table 145. Insulin Syringes Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Insulin Syringes Product Picture
    Figure 2. Global Insulin Syringes Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Insulin Syringes Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Insulin Syringes Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Insulin Syringes Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Insulin Syringes Report Years Considered
    Figure 7. Global Insulin Syringes Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Insulin Syringes Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Syringes Revenue in 2023
    Figure 10. Insulin Syringes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 3/10 CC Syringe Picture
    Figure 12. 1/2 CC Syringe Picture
    Figure 13. 1 CC Syringe Picture
    Figure 14. Others Picture
    Figure 15. Global Insulin Syringes Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Insulin Syringes Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Insulin Syringes Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Insulin Syringes Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Insulin Syringes Price by Type (2019-2030) & (USD/Unit)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Homecare
    Figure 22. Product Picture of Others
    Figure 23. Global Insulin Syringes Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Insulin Syringes Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Insulin Syringes Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Insulin Syringes Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Insulin Syringes Price by Application (2019-2030) & (USD/Unit)
    Figure 28. North America Insulin Syringes Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Insulin Syringes Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Insulin Syringes Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Insulin Syringes Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Insulin Syringes Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Insulin Syringes Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Insulin Syringes Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Insulin Syringes Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Insulin Syringes Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Insulin Syringes Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Insulin Syringes Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Insulin Syringes Sales Volume (%), (2019-2030)
    Figure 40. United States Insulin Syringes Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Insulin Syringes Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Insulin Syringes Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Insulin Syringes Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Insulin Syringes Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Insulin Syringes Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Insulin Syringes Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Insulin Syringes Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Insulin Syringes Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Insulin Syringes Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Insulin Syringes Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Insulin Syringes Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Insulin Syringes Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Insulin Syringes Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Insulin Syringes Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Insulin Syringes Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Insulin Syringes Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Insulin Syringes Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Insulin Syringes Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Insulin Syringes Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Insulin Syringes Sales Value by Application (%), 2023 VS 2030
    Figure 61. Insulin Syringes Industrial Chain
    Figure 62. Insulin Syringes Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS